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Regulatory natural killer cell expression in atopic childhood asthma 
 
 
INTRODUCTION 
Natural killer (NK) cells are large granular 
lymphocytes of the innate immune system that were 
originally defined by their capacity to lyse target 
cells and produce interferon-γ without prior 
activation.1 Various subtypes of NK cells and 
specific NK-derived cytokines/chemokines 
contribute to the promotion/cessation of allergic 
sensitization.2 
In 2008, Deniz et al characterized a regulatory 
subset of NK cell subsets that are characterized by 
IL-10 secretion. This specific subset of cells was 
found to suppress Ag-specific T cell proliferation in 
response to bee venom major allergen, 
phospholipase A2 and purified protein derivative of 
Mycobacterium bovis (PPD), in addition to 
suppression of IgE production. Further 
characterization revealed that these cells express the 
inhibitory killer immunoglobulin-like receptors 
(KIR) (CD158a, CD158b). These cells are termed 
CD56bright and they are capable of killing, not only 
the immature dendritic cell (DC), but also mature 
DC in order to prevent DC over-activation.3 By 
limiting the supply and recruitment of immature 
DC, activated NK cells exert the ability to control 
the subsequent innate and adaptive immune 
responses.3,4 Little is known about the role of 
regulatory NK cells in atopy and asthma. We, 
therefore, sought to investigate the regulatory NK 
cell expression in atopic children with bronchial 
asthma in relation to disease severity and level of 
control. The ultimate objective is to outline the 
value of these cells as novel biomarkers of 
childhood asthma and may pave the way for using 
non-conventional therapeutic modalities. 
 
 
Original article 
Introduction: Different subsets of natural killer (NK) cells were found to 
play a role in pathogenesis of allergy. We sought to investigate the 
expression of regulatory NK cells (CD56+CD16+CD158+) in atopic 
children with bronchial asthma in order to outline the value of these cells as 
biomarkers of disease severity and/or control. Methods: A cross sectional 
controlled study was carried out in the Pediatric Allergy and Immunology 
Unit, Ain Shams University. The study included 45 atopic children [mean 
age(SD)= (2.9) years] with bronchial asthma (BA) and/or allergic rhinitis 
(AR)as well as 40 healthy matched controls. Enrolled subjects underwent 
complete blood counting and flow cytometric measurement of NK cell 
(CD16+ CD56+) and regulatory NK cells (CD16+CD56+CD158+). 
Results:  Patients had significantly higher regulatory NK cell percentages 
[mean (SD)= 41 (52) %] than controls [mean (SD)=15 (7.1)]; p≤0.001. 
Regulatory NK cell counts and percentages did not vary with the 
concomitant presence of AR or the degree of asthma control. Regulatory NK 
cell counts tended to be higher in children with moderate/severe BA 
compared to those with mild asthma but the difference did not reach 
statistical significance (U= -1.8, p=0.06). NK cell counts [mean (SD)= 159 
(164) cells/µl] and percentages [mean (SD)= 3.7 (3.2) %] were comparable 
among patients and controls and did not vary with the presence of AR (p= 
0.51, 0.95) or with the degree of asthma control.  NK cells absolute counts 
and percentages tended to be higher among patients with moderate/severe 
compared to mild asthma but the difference did not reach statistical 
significance. Conclusions: Regulatory NK cells seem to be increased in 
childhood asthma. We recommend wider scale prospective studies on 
steroid-naïve subjects involving measurement of cytokines that are secreted 
by different types of NK cells. 
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METHODS 
 
Study design 
This study is a cross-sectional controlled study that 
was carried out in the Pediatric Allergy and 
Immunology Unit, Children’s Hospital, Ain Shams 
University in the period from May 2014 to June 
2015. 
We enrolled 45 patients with ages ranging 
between two and 12 years, with physician 
diagnosed bronchial asthma with or without allergic 
rhinitis and atopy indicated by positive skin prick 
testing (SPT) to at least one of the common 
environmental aeroallergens). Children with any 
known chronic illness including autoimmune 
diseases or immune-deficiencies were excluded 
from the study. Forty age and sex-matched healthy 
children were enrolled as a control group.  
 
Ethical considerations: 
An informed consent was obtained from parents or 
care givers of all subjects prior to enrollment. The 
study protocol gained approval of the local 
Research Ethics’ Committee of the Pediatric 
Department of Ain Shams University.  
 
Study measurements: 
The patients were subjected to detailed medical 
history taking and physical examination with 
special emphasis on the concomitant presence of 
allergic rhinitis, duration of allergic disease, 
severity of asthma in the last three months, degree 
of asthma control in the month prior to enrollment, 
and related therapeutic history.5   
Asthmatic patients underwent SPT at the time of 
enrolment and only cases with positive results were 
included in the study. We used standardized 
allergen extracts of common environmental 
aeroallergen (house dust mites, alternaria, 
aspergillus, cockroach, cat epithelia, and pollens) as 
well as positive histamine (10 mg/mL) and negative 
saline controls (Omega Laboratories, Montréal, 
Canada).  
Complete blood count (CBC) was performed by 
automated cell counter Coulter MicroDiff 18, 
Fullerton, CA, USA) with manual differential after 
staining with Leishman stain. Flow cytometric 
measurement of NK cells (CD16+ CD56+) and the 
regulatory NK cell subset (CD16+ CD56+ 
CD158+) using EPICS XL flow cytometer (Navios 
Beckman Coulter, USA) was done. Serum total IgE 
was measured in enrolled patients using enzyme 
linked immunosorbent assay (serum IgE ELISA, 
Affymetrix eBioscience, Inc., CA, USA). A serum 
IgE level was considered elevated if it exceeded the 
highest reference value for age.6 
 
Statistical methods: 
Data were collected, revised, coded and entered to 
the Statistical Package for Social Science (IBM 
SPSS) version 20. Numerical parametric data were 
described as mean ± standard deviation (SD) 
together with minimum and maximum range. 
Median and interquartile range (IQR) were used for 
non-parametric data. Categorical data were 
expressed as frequency and percentage. Comparison 
between qualitative data was done using Chi-square 
test and between independent groups with 
parametric continuous variables by Independent t-
test. Non-parametric data were compared using 
Mann-Whitney U test. Spearman correlation 
coefficients were used to assess the relation 
between any two studied parameters. Confidence 
interval was set to 95% and the margin of error 
accepted was set to 5%. p-value was considered 
significant at values ≤ 0.05. 
 
RESULTS 
Patients’ ages ranged between 2.4 and 11.8 years 
with mean±SD of 7.3± 2.9 years. Thirty- two 
(71.1%) of them were boys and 13 (28.9%) were 
girls. Their weight centiles ranged between the 5th 
and 95th centiles for age. Twelve of the asthmatic 
patients had concomitant allergic rhinitis (26.7%). 
The duration of allergic disease ranged from one to 
9 years with a mean±SD of 5.9±2.7 years. The 
control group comprised 40 age- and gender- 
matched healthy children; their ages ranged from 4 
to 12.2 years with mean±SD of 7.5±2.7 years. 
Thirty of the controls were boys (75%) and10 were 
girls (25%). 
Ten children in our series had mild asthma 
(22.2%), 30 (66.7%) had moderate and 5 patients 
had severe asthma (11.1%). According to GINA 
guidelines5 for asthma control, 24 patients (53.3%) 
had well controlled, 15 patients (33.3%) had 
partially controlled and 6 patients (13.3%) had 
uncontrolled asthma at the time of enrollment. 
Differential leukocyte counts and flow-
cytometric results for NK and regulatory NK cells 
among patients and controls are depicted in table 1. 
The asthmatic children had significantly lower 
weight percentiles for age and significantly higher 
regulatory NK cell percentages in comparison to the 
control group. 
Patients with exclusive bronchial asthma (n=35) 
were comparable to those with concomitant AR 
(n=12) in terms of total leukocyte count (p=0.347), 
absolute lymphocyte count (p=0.257), absolute 
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eosinophil count (p=0.521), and relative and 
absolute counts of NK cells (p = 0.96 and 0.51, 
respectively) and regulatory NK cells (p = 0.7 and 
0.65, respectively), as well as the total serum IgE 
levels (p= 0.173). 
Patients with different grades of asthma severity 
were comparable in terms of their CBC counts, NK 
and regulatory NK cell counts or percentages and 
their total serum IgE levels. Although the absolute 
eosinophil and regulatory NK cell counts were 
slightly higher among patients with 
moderate/severe versus mild asthma, the differences 
did not reach statistical significance (table 2). 
Moreover, Patients with different degrees of asthma 
control were comparable in terms of their CBC 
counts, and NK and regulatory NK cell absolute 
counts and percentages, as well as total serum IgE 
levels (table 3). 
Regulatory NK cell counts correlated positively 
with the total leucocyte counts of the asthmatic 
children (Figure 1). Neither absolute eosinophil 
count nor total IgE level showed any significant 
correlation with NK cell or its regulatory subset 
counts. 
 
Table 1. Variation of blood cell counts among patients and controls. 
 
Variables Patients (n=45) Controls (n=40) Test value p 
TLC x103/µl 
Min-Max 5.4-15.8 5.4-13.4 
-0.819 # 0.413 
Median (IQR) 10 (4.6) 9.2 (3.3) 
ALC x103/µl 
Min-Max 1.52-9.4 1.6-8.04 
-1.3 # 0.164 
Median (IQR) 3.5 (2.6) 3.1 (2) 
Lymphocyte % 
Min-Max 15.5-62 15.3-62.3 
-0.814 # 0.415 
Median (IQR) 42.8 (15) 37 (23) 
ANC x103/µl 
Min-Max 2-9 1.4-8.3 
-0.225 # 0.822 
Median (IQR) 4 (2.4) 4.2 (2) 
AEC x103/µl 
Min-Max 0.0125-0.7 0.017-0.84 
-1.03 # 0.301 
Median (IQR) 0.2 (0.31) 0.231 (0.11) 
NK cell count /µl 
Min-Max 15-623 10-984 
-0.56 # 0.58 
Median (IQR) 96 (217) 118 (119) 
NK % 
Min-Max 0.5-11.9 0.5-13.3 
1.28 # 0.19 
Median (IQR) 2.4 (5.1) 3 (3.9) 
Regulatory NK cell count/µl 
Min-Max 1-215 2-104 
-0.269 # 0.788 
Median (IQR) 30 (40) 15 (25.2) 
Regulatory NK % 
Min-Max 7.3-61.8 2.7-29.8 
-3.896 # 0.00 * 
Median (IQR) 28.1 (23.7) 15 (11.1) 
ALC: absolute lymphocyte count; AEC: absolute eosinophil count; ANC: absolute neutrophil count; IQR: interquartile range; 
NK: natural killer cell; Max: maximum; TLC: total leucocyte count; SD: standard deviation; ● Chi square test; # Mann-
Whitney test; * statistically significant. 
 
  
Figure 1. Positive correlation between total leukocyte and regulatory NK cell counts 
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Table 2. Variation of the laboratory data according to asthma severity. 
 
p value U Test Moderate/Severe (n=35) Mild (n=10) Parameter 
0.58 -0.56 
5.4-15.8 6-13.4 Min-Max 
TLC (103/µl) 
9.2 (4) 9.4 (6.2) Median (IQR) 
0.39 -0.87 
1.5-9.4 1.8-5.7 Min-Max 
ALC (103/µl) 
3.4 (2.6) 3.4 (1.8) Median (IQR) 
0.904 -0.13 
16.4-62.1 15.5-55.3 Min-Max 
Lymphocyte (%) 
42 (16.4) 34 (13.1) Median (IQR) 
0.94 -0.08 
2-8 2-9 Min-Max 
ANC (103/µl) 
4.1 (2.3) 3.7 (3) Median (IQR) 
0.06 -1.8 
0.013-2 0.012-0.53 Min-Max 
AEC (103/µl) 
0.23 (0.39) 0.09 (0.19) Median (IQR) 
0.75 -0.31 
35-800 110-275 Min-Max 
IgE (IU/ml) 
220 (190) 227 (74) Median (IQR) 
0. 09 -1.6 
16-623 15-359 Min-Max 
NK cell count (/µl) 
113 (266) 61 (43) Median (IQR) 
0.11 -1.5 
0.5-11.9 0.5-8 Min-Max 
NK cell (%) 
3.2 (5.7) 1.3 (2.5) Median (IQR) 
0.06 -1.8 
1-215 4-39 Min-Max 
Reg NK cell count (/µl) 
34 (48) 12 (14) Median (IQR) 
0.9 -0.12 
7.7-59.1 7.3-61.8 Min-Max 
Reg NK cell (%) 
26 (24.9) 30.7 (23.8) Median (IQR) 
AEC: absolute eosinophil count; ALC: absolute lymphocyte count; ANC: absolute neutrophil count; Min: 
minimum; Max: maximum; NK: natural killer; Reg NK: regulatory natural killer; TLC: total leucocyte count; 
SD standard deviation; U: Mann Whitney test. 
 
 
Table 3. Variation of the laboratory data according to degree of asthma control 
 
p U Test 
Asthma control 
Parameters 
Partial or Non (n=21)  Good (n=24) 
0.86 -0.17 
5.5-15.8 5.4-14.5 Min-Max 
TLC (103/µl) 9.8 (± 2.9) 9.6 (± 2.6) Mean (SD) 
10 (5) 9.7 (4.5) Median (IQR) 
0.228 -0.12 
1.5-9.4 1.8-7.9 Min-Max 
ALC (103/µl) 
4.8 (2.9) 3.4 (1.9) Median (IQR) 
0.14 -1.4 
25.4-62 15.5-55.4 Min-Max 
Lymphocyte (%) 
45 (13.6) 42.2 (15.6) Median (IQR) 
0.7 -0.34 
2.1-8.2 2-9 Min-Max 
ANC (103/µl) 
3.9 (2.8) 4 (2.3) Median (IQR) 
0.82 -0.216 
0.03-0.6 0.012-0.7 Min-Max 
AEC (103/µl) 
0.14 (0.28) 0.2 (0.33) Median (IQR) 
0.62 -0.49 
103-495 35-800 Min-Max 
IgE (IU/ml) 
230 (102) 204 (144) Median (IQR) 
0.17 -1.3 
16-563 15-623 Min-Max 
NK count per µl) 
115 (193) 57 (224) Median (IQR) 
0.47 -0.71 
0.6-11.9 0.5-8.7 Min-Max 
NK % 
2.5 (5.5) 2.39 (4.8) Median (IQR) 
0.18 -1.3 
1-215 16-563 Min-Max 
Reg NK count per µl) 
32 (43) 13 (35) Median (IQR) 
0.34 -0.94 
7.7-59.1 7.3-61.8 Min-Max 
Reg NK (%) 
30 (26.8) 25.2 (18.9) Median (IQR) 
AEC: absolute eosinophil count; ALC: absolute Lymphocyte count; ANC: absolute neutrophil count; 
Min: minimum; Max: maximum; NK: natural killer cell; Reg NK: regulatory natural killer cell; TLC: 
total leucocyte count; SD standard deviation; U: Mann Whitney test.  
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DISCUSSION 
In the current study, regulatory NK cells, identified 
by the expression of CD16+CD56 +CD158+, were 
significantly higher in asthmatic patients compared 
to controls. Thus, although the total NK cell counts 
were not elevated in our series, there was relative 
over expression of the regulatory subset. Regulatory 
NK cells, however, did not vary significantly with 
the coexistence of allergic rhinitis. The small 
sample size and enrollment while under therapy 
might have affected our results. Regulatory NK 
cells, characterized by IL-10– and TGF-β–
secretion, were previously reported to play major 
roles in immune regulation in the context of viral 
infection and they are thought to promote transplant 
and pregnancy tolerance.16 IL-10 has been shown to 
suppress both cytokine production and antigen-
specific proliferation of T-helper 1 (Th1) and Th2 
cells.17 In 2015, Deniz et al demonstrated an 
increase in percentage of both IL-10 secreting 
regulatory NK and IL-4 NK2 subsets in atopic 
patients with allergic rhinitis in comparison with 
healthy controls.18 
Among our series, regulatory NK cell absolute 
counts tended to be higher among patients with 
moderate/severe asthma versus those with mild 
asthma but the difference did not reach statistical 
significance. This finding might be limited by the 
sample size. Regulatory NK cell relative and 
absolute counts did not vary significantly with the 
degree of asthma control in our subjects despite 
seemingly higher percentage values among the 
partially controlled/uncontrolled group. The 
elevation of regulatory NK cells among asthmatic 
patients might occur in the context of allergic 
reaction control attempts. The expected increase in 
IL-10 secretion may thereby decrease levels of Th2 
cytokines and suppress proinflammatory Th1 
cytokine secretion, thus decreasing host tissue 
damage.19-21 Further studies linking the regulatory 
NK cells to viral replication and cytokine secretions 
may elucidate the actual role of NK regulatory cell 
subset in respiratory allergy. 
The total counts and percentages of 
CD16+CD56+ NK cells were comparable among our 
atopic children and matched controls. Also, their 
expression did not vary significantly with the 
coexistence of allergic rhinitis or the degree of 
asthma control. However, NK cells absolute counts 
and percentages tended to be higher among patients 
with moderate/severe asthma as compared to mild 
asthma, but the difference did not reach statistical 
significance. Several studies have addressed the 
role of total NK cells in allergy.7-11 A relevant study 
that included 12 adult atopic patients with history of 
allergic rhinitis (mean age 33 years) of whom four 
had concomitant asthma, reported that a NK cell 
subpopulation expressing CD56+CD16+ (INF-γ 
secreting) was significantly reduced in the patients 
as compared to 9 non-atopic healthy controls. Also, 
patients’ NK cells showed decreased capability of 
inducing dendritic cell maturation and proliferation, 
proved by assessment of IL-12 secretion. The 
authors concluded that allergic diseases may be 
characterized by an impairment of peripheral blood 
NK cells to interact with dendritic cell and promote 
and maintain appropriate TH-1 responses. 12  
In another study, a significant decrease in NK 
(CD16+ CD56+) cell count was demonstrated in the 
peripheral blood of 20 children with atopic 
dermatitis (AD) as compared to 20 matched healthy 
children. The authors attributed this reduction in 
peripheral NK cell numbers to chemokine-
dependent NK cell recruitment from peripheral 
blood to the inflamed skin.13 Similar findings were 
also previously reported by Katsuta et al. (2006).14 
In animal models, increased NK cells were 
observed in the lung following antigen 
challenge.11In asthmatics, the NK cell phenotype 
was found to be altered and may thus contribute to 
the promotion of a proinflammatory Th2-type 
environment.2 The ability of NK cells to produce 
Th2-type cytokines and their pivotal role in 
combating respiratory infections which cause 
airway dysfunction in asthmatics suggest that they 
may directly contribute to the immunopathogenesis 
of allergic airway disease.15 
In our series, house dust mite was the most 
common aeroallergen causing sensitization among 
our patients (93%), followed by aspergillus (33%) 
and cockroach allergens (8%). Our results are 
supported by previous studies conducted on 
asthmatic children from our community.22,23   
Our study has some limitations; it was 
conducted in a cross-sectional pattern on a small 
sample. Second, all patients enrolled were on 
treatment including inhaled and/or intranasal 
corticosteroids. Assessment of both total and 
regulatory NK cells in steroid naïve allergic patients 
might reveal the effect of treatment on NK cell.  We 
also relied on detecting surface receptors for 
recognizing NK and regulatory NK cell subsets 
while measuring cytokine secretion by NK cell 
subsets could have provided more conclusive 
results. Finally, the age range was wide in respect to 
our sample size and this may have impeded the 
interpretation of data as inflammatory parameters 
do vary with age.        
In conclusion, the results of this pilot study show 
that regulatory NK cell are increased in asthmatic 
children and may have a tendency to increase with 
severity. A possible protective role in the context of 
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asthma pathogenesis needs verification from wider 
scale studies. These should involve measurement of 
different pro- and anti- inflammatory cytokines and 
viral loads in correlation to regulatory NK cells. 
Studies investigating the impact of blocking the 
action of regulatory NK cells in respiratory allergy 
might also unmask their role whether protective or 
pathogenic and may have possible therapeutic 
potentials. 
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